The human HPS subtypes (HPS1-HPS11) have different clinical features to some extent, whereas the disease spectrum is nearly identical in patients with mutations in different components of the same protein complex (Bowman et al., 2019; Dell’Angelica, 2004; Huizing et al., 2008b). This evidence concerns the gene BLOC1S5 and Hermansky-Pudlak syndrome.